Career history of Lars Gösta Jonsson
Former positions of Lars Gösta Jonsson
| Companies | Position | Start | End |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2001 | 01/01/2005 |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/01/1999 | 01/01/2003 |
| Astra Arcus AB | President | 01/01/1989 | 01/01/1999 |
| Pharmacia Ophthalmics AB | Corporate Officer/Principal | 01/01/1986 | 01/01/1989 |
| Karolinska Institutet | Corporate Officer/Principal | 01/01/1967 | 01/01/1986 |
Mando AB
 Mando AB Medical/Nursing ServicesHealth Services Mando AB engages in the provision of health care services. It offers treatment for anorexia nervosa and bulimia nervosa as well as other eating disorders using Mandometer Method. The company was founded in 2000 and is headquartered in Huddinge, Sweden. | Director/Board Member | - | - |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Synosia Therapeutics, Inc. used to develop products for unmet medical needs in psychiatry and neurology. The company was founded in December 2005 and was headquartered in San Francisco, CA. | Director/Board Member | 11/03/2010 | - |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Director/Board Member | 26/04/2010 | - |
| Corporate Officer/Principal | - | 26/04/2010 | |
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Statistics
International
| Sweden | 8 |
| United States | 3 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 7 |
| Director/Board Member | 5 |
| President | 1 |
Sectoral
| Health Technology | 6 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BIOARCTIC AB | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Private companies | 7 |
|---|---|
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Commercial Services |
| Pharmacia Ophthalmics AB | |
| Astra Arcus AB | |
BioPhausia AB
BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Distribution Services |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Health Technology |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Synosia Therapeutics, Inc. used to develop products for unmet medical needs in psychiatry and neurology. The company was founded in December 2005 and was headquartered in San Francisco, CA. | Health Technology |
Mando AB
Mando AB Medical/Nursing ServicesHealth Services Mando AB engages in the provision of health care services. It offers treatment for anorexia nervosa and bulimia nervosa as well as other eating disorders using Mandometer Method. The company was founded in 2000 and is headquartered in Huddinge, Sweden. | Health Services |
- Stock Market
- Insiders
- Lars Gösta Jonsson
- Experience
